The OIG issued a report finding that while FDA inspection of generic manufacturers is up, those inspections are not as thorough as they could be.
A new PhRMA report released Monday found that branded manufacturers invested $51.2 billion last year in R&D.
The National Minority Quality Forum on Tuesday honored PhRMA's John Castellani, for helping to increase diversity in clinical trials.
DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.
Generic Pharmaceutical Association branches out with the creation of the Biosimilars Council.
According to the Food and Drug Administration, heart failure is a common condition that affects close to 5.1 million people in the United States. The condition arises when the heart cannot pump enough blood to meet the body’s needs.
Supplement industry under continued fire with latest criticism of FDA oversight of BMPEA ingredient coming from Sen. Chuck Schumer, D-N.Y.
Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday.
The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.
The supplement industry criticized the agreement between GNC and the New York Attorney General's office.
GNC on Monday announced an agreement with the New York Attorney General's office affirming that all of the products called into question by the office were actually in full compliance with cGMPs.
The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products.
In a letter to the Senate, the Food and Drug Administration acknowledged that DNA barcoding is not routinely used to identify botanical ingredients.
The Food and Drug Administration recently published bio-equivalence guidance documents.
DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.
The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.
Nutramax Labs announced Thursday the results of a National Institutes of Health-funded clinical study carried out at the Fred Hutchinson Cancer Research Center in Seattle.
The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.
The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change.
NPA renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.
Combined Distributors reported that its medicine disposal product was found to exceed U.S. FDA and EPA guidelines.
The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.
The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.
Food and Drug Commissioner Margaret Hamburg will resign from her post in March.
DSN examines chain pharmacy, including in-depth coverage of telehealth, generic drug prices, and the GPhA CEO to step down, as well as Uhl appointed director of OGD, in this multi-page report.